NCT00522951 2017-08-28SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative StudyBayerPhase 3 Completed165 enrolled 24 charts
NCT01067976 2014-11-11Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRIBayerPhase 3 Completed446 enrolled 30 charts